Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?

MeSH terms

• Antibodies, Monoclonal, Humanized / administration & dosage
• Antibodies, Monoclonal, Humanized / adverse effects
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Antineoplastic Agents, Immunological / administration & dosage
• Antineoplastic Agents, Immunological / adverse effects
• Antineoplastic Agents, Immunological / therapeutic use*
• B7-H1 Antigen / antagonists & inhibitors*
• Humans
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / metabolism
• Lung Neoplasms / mortality
• Lung Neoplasms / pathology*
• Neoplasm Staging
• Treatment Outcome